Patient-derived acute myeloid leukemia (AML) bone marrow cells display distinct intracellular kinase phosphorylation patterns

References

• StoneRMO’DonnellMRSekeresMAAcute myeloid leukemiaHematology Am Soc Hematol Educ Program20049811715561679
   PubMedGoogle Scholar
• CorrellPHPaulsonRFWeiXMolecular regulation of receptor tyrosine kinases in hematopoietic malignanciesGene2006374263816524673
   PubMed Web of Science ®Google Scholar
• KornblauSMTibesRQiuYHFunctional proteomic profiling of AML predicts response and survivalBlood2009113115416418840713
   PubMed Web of Science ®Google Scholar
• DeAngeloDJStoneRMHeaneyMLPhase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamicsBlood2006108123674368116902153
   PubMed Web of Science ®Google Scholar
• FiedlerWMestersRTinnefeldHA phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemiaBlood200310282763276712843001
   PubMed Web of Science ®Google Scholar
• FiedlerWServeHDohnerHA phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the diseaseBlood2005105398699315459012
   PubMed Web of Science ®Google Scholar
• O’FarrellAMAbramsTJYuenHASU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoBlood200310193597360512531805
   PubMed Web of Science ®Google Scholar
• O’FarrellAMForanJMFiedlerWAn innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patientsClin Cancer Res20039155465547614654525
   PubMed Web of Science ®Google Scholar
• O’FarrellAMYuenHASmolichBEffects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemiaLeuk Res200428767968915158089
   PubMed Web of Science ®Google Scholar
• StoneRMDeAngeloDJKlimekVPatients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Blood20051051546015345597
   PubMed Web of Science ®Google Scholar
• KellyLMYuJCBoultonCLCT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)Cancer Cell20021542143212124172
   PubMed Web of Science ®Google Scholar
• TseKFNovelliECivinCIBohmerFDSmallDInhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitorLeukemia20011571001101011455967
   PubMed Web of Science ®Google Scholar
• PratzKWCortesJRobozGJA pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical responseBlood20081124 [Epub ahead of print].
   Google Scholar
• IrishJMHovlandRKrutzikPOSingle cell profiling of potentiated phospho-protein networks in cancer cellsCell2004118221722815260991
   PubMed Web of Science ®Google Scholar
• PerezODNolanGPPhospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell levelImmunol Rev200621020822816623773
   PubMed Web of Science ®Google Scholar
• TongFKChowSHedleyDPharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cellsCytometry B Clin Cytom200670310711416498671
   PubMed Web of Science ®Google Scholar
• KrutzikPONolanGPIntracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling eventsCytometry A2003552617014505311
   PubMed Web of Science ®Google Scholar
• WangLGaigalasAAbbasiFMartiGVogtRSchwartzAQuantitating fluorescence intensity from fluorophores: practical use of MESF valuesJ Res Natl Inst Stand Technol2002107339353
   PubMed Web of Science ®Google Scholar
• AdidaCRecherCRaffouxEExpression and prognostic significance of survivin in de novo acute myeloid leukaemiaBr J Haematol2000111119620311091201
   PubMed Web of Science ®Google Scholar
• TammIRichterSOltersdorfDHigh expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemiaClin Cancer Res200410113737374415173080
   PubMed Web of Science ®Google Scholar
• OtoOAPaydasSTanriverdiKSeydaogluGYavuzSDiselUSurvivin and EPR-1 expression in acute leukemias: prognostic significance and review of the literatureLeuk Res200731111495150117328950
   PubMed Web of Science ®Google Scholar
• ChowSMindenMDHedleyDWConstitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patientsExp Hematol200634911821191
   Web of Science ®Google Scholar
• CraigFEFoonKAFlow cytometric immunophenotyping for hematologic neoplasmsBlood200811183941396718198345
   PubMed Web of Science ®Google Scholar
• BorowitzMJGuentherKLShultsKEStelzerGTImmunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysisAm J Clin Pathol199310055345408249893
   PubMed Web of Science ®Google Scholar
• AdamsCLGriersonAMMowatAMHarnettMMGarsidePDifferences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometryJ Immunol200417331579158615265885
   PubMed Web of Science ®Google Scholar
• MilneCDCorfeSAPaigeCJHeparan sulfate and heparin enhance ERK phosphorylation and mediate preBCR-dependent events during B lymphopoiesisJ Immunol200818052839284718292505
   PubMed Web of Science ®Google Scholar
• BrunningRDMatutesENLHAcute myeloid leukaemia: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid TissuesLyon, FranceIARC Press2001
   Google Scholar
• ThiedeCSteudelCMohrBAnalysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisBlood200299124326433512036858
   PubMed Web of Science ®Google Scholar